-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 MPkHbW1v+Dic6WBOxCaQRRPZfLBMiweJsV0SuawO6+v+NriBRXaffVBkqYhPVwXj
 eBL7s9yQgiMBCt2lUajsqA==

<SEC-DOCUMENT>0001209191-06-059584.txt : 20061115
<SEC-HEADER>0001209191-06-059584.hdr.sgml : 20061115
<ACCEPTANCE-DATETIME>20061115155450
ACCESSION NUMBER:		0001209191-06-059584
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20061114
FILED AS OF DATE:		20061115
DATE AS OF CHANGE:		20061115

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adams Respiratory Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001319439
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				752725552
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	BUSINESS ADDRESS:	
		STREET 1:		4 MILL RIDGE LANE
		CITY:			CHESTER
		STATE:			NJ
		ZIP:			07930
		BUSINESS PHONE:		(908) 879-1400

	MAIL ADDRESS:	
		STREET 1:		4 MILL RIDGE LANE
		CITY:			CHESTER
		STATE:			NJ
		ZIP:			07930

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adams Laboratories, Inc.
		DATE OF NAME CHANGE:	20050302

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adams Respiratory Therapeutics, Inc.
		DATE OF NAME CHANGE:	20050301

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Lilly John N
		CENTRAL INDEX KEY:			0001342353

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51445
		FILM NUMBER:		061219970

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		612-330-5066

	MAIL ADDRESS:	
		STREET 1:		4900 IDS CENTER
		STREET 2:		80 SOUTH EIGHTH STREET
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55402
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2006-11-14</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001319439</issuerCik>
        <issuerName>Adams Respiratory Therapeutics, Inc.</issuerName>
        <issuerTradingSymbol>ARXT</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001342353</rptOwnerCik>
            <rptOwnerName>Lilly John N</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>4900 IDS CENTER</rptOwnerStreet1>
            <rptOwnerStreet2>80 SOUTH EIGHTH STREET</rptOwnerStreet2>
            <rptOwnerCity>MINNEAPOLIS</rptOwnerCity>
            <rptOwnerState>MN</rptOwnerState>
            <rptOwnerZipCode>55402</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2006-11-14</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>P</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>700</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>42.94</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>3365</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes></footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>/s/ Brad Cole, Attorney-in-fact</signatureName>
        <signatureDate>2006-11-15</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----